Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.


Subscribe or Register

Existing user? Login


Health literacy

Information sheet helps educate isotretinoin users about effective contraception

Researchers evaluated the impact of an information sheet on contraceptive knowledge in women taking the acne drug isotretinoin

Source: BSIP SA / Alamy

Women using the acne drug isotretinoin, which is a known teratogen, are advised to use two forms of contraception

The acne medication isotretinoin is a known teratogen and it is recommended that women taking the drug use two forms of contraception. Nevertheless, isotretinoin-exposed pregnancies still occur, largely in women using contraceptives with high failure rates.

To educate women about different contraception methods, US researchers developed a one-page information sheet covering eight popular approaches to birth control. They then evaluated the tool through a survey of 100 women aged 18–45 years visiting a dermatology practice.

The women’s contraceptive knowledge – including their awareness of different methods and assessment of each method’s effectiveness – increased significantly after they had viewed the information sheet. The researchers conclude in JAMA Dermatology (online, 4 February 2015)[1] that the sheet “may be a useful addition to efforts to prevent isotretinoin-induced birth defects”. 

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2015.20067828

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.